Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general.
暂无分享,去创建一个
A Simon Pickard | David Cella | Jin-Shei Lai | D. Cella | J. Lai | A. Pickard | Deborah Dobrez | Angel Nickolov | D. Dobrez | A. Nickolov | PhD Deborah Dobrez | PhD David Cella | PhD A. Simon Pickard | PhD Jin-Shei Lai | MS Angel Nickolov
[1] D. Tulsky,et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. , 1995, Lung cancer.
[2] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[3] D. Feeny,et al. Health Utilities Index Mark 3 , 2016 .
[4] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[5] R. Deyo,et al. The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. , 2002, Health economics.
[6] William F Lawrence,et al. Predicting EuroQoL EQ-5D Preference Scores from the SF-12 Health Survey in a Nationally Representative Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[7] W. Catalona,et al. Patient preferences for outcomes associated with surgical management of prostate cancer. , 2002, The Journal of urology.
[8] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] D. Feeny,et al. The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies , 2001, Annals of medicine.
[10] J. Pater. Quality of life and pharmacoeconomics in clinical trials , 1996 .
[11] Leslie E. Papke,et al. Econometric Methods for Fractional Response Variables with an Application to 401(K) Plan Participation Rates , 1993 .
[12] G. Bonsel,et al. The comparability and reliability of five health-state valuation methods. , 1997, Social science & medicine.
[13] J. Brazier,et al. Deriving a preference-based single index from the UK SF-36 Health Survey. , 1998, Journal of clinical epidemiology.
[14] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[15] K C Cain,et al. Measuring Preferences for Health States Worse than Death , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.
[16] Lisa M. Schwartz,et al. Assessing Values for Health: Numeracy Matters , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[17] J. V. Von Roenn,et al. Defining Higher Order Dimensions of Self-Reported Health , 2005, Evaluation & the health professions.
[18] J. Brazier,et al. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D , 2003, Health and quality of life outcomes.
[19] B. Spilker,et al. Quality of life and pharmacoeconomics in clinical trials , 1996 .
[20] E. Calhoun,et al. Testing subject comprehension of utility questionnaires , 2004, Quality of Life Research.
[21] M. Drummond. Introducing economic and quality of life measurements into clinical studies , 2001, Annals of medicine.
[22] M Johannesson,et al. The Relationship between Health-state Utilities and the SF-12 in a General Population , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[23] P. Kind,et al. “Death” and the Valuation of Health-Related Quality of Life , 2001, Medical care.
[24] S. Jansen,et al. Stability of Patients’ Preferences for Chemotherapy , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[25] D. Feeny,et al. Responsiveness of generic health-related quality of life measures in stroke , 2005, Quality of Life Research.